Anti-Microbial Savior BioteQ Co., Ltd. (TPEX:6864)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
41.30
+0.10 (0.24%)
Aug 4, 2026, 12:54 PM CST
Market Cap1.59B -42.4%
Revenue (ttm)706.00K +11.5%
Net Income-93.60M
EPS-2.88
Shares Out 37.82M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume16,030
Open41.20
Previous Close41.20
Day's Range40.05 - 41.50
52-Week Range40.00 - 96.20
Beta-0.08
Analystsn/a
Price Targetn/a
Earnings DateAug 13, 2026

About TPEX:6864

Anti-Microbial Savior BioteQ Co., Ltd. focuses on the research and development of pharmaceutical drug products in Taiwan. The company offers PoroVance precision pore engineering and small-molecule drug discovery. Its pipeline products include FORMOSA-1117, antibacterial drug candidate; YUAN-03, antiviral drug candidate; AMS-2140, broad-spectrum antiviral drug candidate; TenTacle, ADC linker-conjugate compound. Anti-Microbial Savior BioteQ Co., Ltd. was founded in 2018 and is headquartered in Kaohsiung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6864
Full Company Profile

Financial Performance

In 2025, TPEX:6864's revenue was 706,000, an increase of 15.36% compared to the previous year's 612,000. Losses were -93.60 million, 25.6% more than in 2024.

Financial Statements